Elanco Animal Health Inc (ELAN) director gifts 60,000 shares

Rhea-AI Filing Summary

Elanco Animal Health Inc director reports charitable stock gift. Director R. David Hoover reported a transaction dated 12/19/2025 involving Elanco common stock. The filing shows that a revocable trust associated with him disposed of 60,000 shares as a gift to a charitable trust at a reported price of $0 per share.

After this gift, he is shown as beneficially owning 150,000 shares indirectly through a revocable trust, 106,773 shares directly, and 15,920 shares indirectly through the Suzanne A. Hoover Revocable Trust. This reflects a shift in how part of his holdings are allocated, with shares redirected to charitable purposes while maintaining substantial ownership interests.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOOVER R DAVID

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/19/2025		G(1)		60,000	D	$0	150,000	I	Revocable Trust
Common Stock								106,773	D
Common Stock								15,920	I	Suzanne A. Hoover Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reported transaction is a gift of shares to a charitable trust.

	/s/ Amy C. Seidel, as Attorney-in-Fact for R. David Hoover	12/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Elanco Animal Health Inc (ELAN) report?

The report shows that director R. David Hoover, through a revocable trust, made a gift of 60,000 shares of Elanco common stock to a charitable trust on 12/19/2025.

What is the transaction type for the 60,000 Elanco (ELAN) shares?

The 60,000 Elanco common shares are coded as transaction type G, which the explanation identifies as a gift of shares to a charitable trust.

How many Elanco shares does R. David Hoover beneficially own after the reported gift?

After the transaction, the report lists 150,000 shares held indirectly through a revocable trust, 106,773 shares held directly, and 15,920 shares held indirectly through the Suzanne A. Hoover Revocable Trust.

Who is the insider involved in this Elanco Animal Health Inc (ELAN) Form 4?

The insider is R. David Hoover, identified as a director of Elanco Animal Health Inc, with the form filed for one reporting person.

Was the Elanco (ELAN) insider transaction a purchase or sale for value?

The reported transaction is a gift of 60,000 shares to a charitable trust at a stated price of $0 per share, rather than a purchase or sale for value.

Are there any derivative securities reported for Elanco (ELAN) in this filing?

The section for derivative securities is present but contains no reported derivative transactions or holdings in the provided content.